Advertisement
Screener

FORTREA HOLDINGS INC. (FTRE) Graph

Add as a preferred source on Google

FTRE Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $678.20M; Selling, general and administrative $102.10M; Income tax $12.00M; Net income -$13.20M.
  • 2026-03-31: Revenue $636.50M; Selling, general and administrative $100.50M; Income tax $11.30M; Net income -$23.60M.
  • 2025-12-31: Revenue $660.50M*; Selling, general and administrative $103.00M*; Income tax -$3.10M*; Net income -$35.30M*.
  • 2025-09-30: Revenue $701.30M; Selling, general and administrative $106.80M; Income tax -$12.80M; Net income -$15.90M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

FTRE revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Europe$219.70MNorth America$319.70MOther GeographicalAreas$138.80MRevenue$678.20MOperating income$14.80MOther income, net-$200.00KSelling, general& administrative$102.10MPre-tax income-$1.20MIncome tax$12.00MNet income-$13.20M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueSelling, general and administrativeIncome taxNet income
2026-06-30$678.20M$102.10M$12.00M-$13.20M
2026-03-31$636.50M$100.50M$11.30M-$23.60M
2025-12-31$660.50M*$103.00M*-$3.10M*-$35.30M*
2025-09-30$701.30M$106.80M-$12.80M-$15.90M
2025-06-30$710.30M$124.80M$4.20M-$374.90M
2025-03-31$651.30M$121.80M$14.90M-$562.90M
2024-09-30$674.90M$136.30M-$17.30M-$27.90M
2024-06-30$662.40M$156.20M$10.70M-$138.40M
2024-03-31$662.10M$120.10M$4.10M-$101.00M
2023-09-30$713.80M$106.80M-$5.80M-$14.00M
2023-06-30$725.10M$97.80M$11.60M$30.80M
2023-03-31$693.90M$116.80M$1.50M$12.50M
2022-09-30$762.30M$70.70M$13.60M$60.60M
2022-06-30$793.10M$71.20M$17.20M$66.40M
2022-03-31(m)(m)(m)$32.50M

Revenue and expense 6 month

Period endRevenueSelling, general and administrativeIncome taxNet income
2026-06-30$1.31B$202.60M$23.30M-$36.80M
2025-06-30$1.36B$246.60M$19.10M-$937.80M
2024-06-30$1.32B$276.30M$14.80M-$239.40M
2023-06-30$1.42B$214.60M$13.10M$43.30M
2022-06-30$1.57B$145.80M$22.20M$98.90M

Revenue and expense 9 month

Period endRevenueSelling, general and administrativeIncome taxNet income
2025-09-30$2.06B$353.40M$6.30M-$953.70M
2024-09-30$2.00B$412.60M-$2.50M-$267.30M
2023-09-30$2.13B$321.40M$7.30M$29.30M
2022-09-30$2.33B$216.50M$35.80M$159.50M

Revenue and expense 12 month

Period endRevenueSelling, general and administrativeIncome taxNet income
2025-12-31$2.72B$456.40M$3.20M-$989.00M
2024-12-31$2.70B$560.70M-$3.50M-$329.00M
2023-12-31$2.84B$448.10M$1.20M-$25.00M
2022-12-31$2.84B$416.10M$41.10M$186.20M
2021-12-31$3.06B$303.10M$38.40M$98.00M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CareDx, Inc. (CDNA)United States$3.174B13.21
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advertisement